- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
May 01, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
From Benzinga
Germany's Possible Export Ban On Semiconductor Chemicals To China: What It Means For The U.S
April 27, 2023
From Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
From Benzinga
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
April 27, 2023
From MarketWatch
Why Merck Stock Is Trading Higher Today
April 27, 2023
From Benzinga
From Motley Fool
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023
From Motley Fool
Meta Platforms stock rallies on results, Mobileye Global stock sinks and other stocks on the move
April 27, 2023
From MarketWatch
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
April 27, 2023
From Benzinga
An undiscovered universe of stocks is trading at ‘near generational lows,’ asset manager says
April 27, 2023
From MarketWatch
The 7 Best Stocks From Schwab’s Dividend ETF
April 26, 2023
From InvestorPlace
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
From Motley Fool
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 24, 2023
From InvestorPlace
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
From Benzinga
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
From Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.